|
|
|
|
|
|
|
|
|
|
|
01.06.26 - 21:03
|
IBA – ACQUISITION OF OWN SHARES (GlobeNewswire EN)
|
|
|
Louvain-la-Neuve, Belgium, June 1st, 2026 – 9 PM CEST – In accordance with article 8:4 of the Royal Decree of 29 April 2019 executing the Belgian Code on Companies and Associations, Ion Beam Applications SA (“IBA”) hereby discloses information in relation to its share buyback program announced on February 2nd, 2026....
|
|
|
|
|
|
|
|
|
01.06.26 - 07:03
|
IBA launches Cyclone® iKure, a cyclotron designed for industrial scale Astatine-211 production (GlobeNewswire EN)
|
|
|
Louvain-la-Neuve, Belgium – 01 June 2026 – IBA (Ion Beam Applications S.A., EURONEXT), the world leader in particle accelerator technology and the leading provider of radiopharmaceutical production solutions, today launches Cyclone® iKure, a dedicated cyclotron for routine Astatine-211 (At-211) production. Designed for alpha-beam irradiation, this new cyclotron enables radiopharmaceutical manufacturers, research institutions and healthcare providers to accelerate access to targeted alpha therapies with the reliability and quality required for clinical-scale programs....
|
|
|
|
|
|
|
26.05.26 - 18:03
|
IBA – ACQUISITION OF OWN SHARES (GlobeNewswire EN)
|
|
|
Louvain-la-Neuve, Belgium, May 26th, 2026 – 6 PM CEST – In accordance with article 8:4 of the Royal Decree of 29 April 2019 executing the Belgian Code on Companies and Associations, Ion Beam Applications SA (“IBA”) hereby discloses information in relation to its share buyback program announced on February 2nd, 2026....
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|